BACKGROUND: Capsule endoscopy (CE) is performed to assess inflammatory bowel disease (IBD). We aimed to define the results of CE in subtypes of IBD and to determine whether CE results in management changes. METHODS: A retrospective cohort study was performed of all CEs for IBD at a tertiary care center from 2003-2009. Descriptive statistics were used to compare IBD-specific medications, surgeries, and imaging studies in the 3 months prior and 3 months after CE. RESULTS: Of 907 CEs performed from 2003-2009, 128 were for an indication of symptomatic IBD and 124 capsules left the stomach (86 for Crohn's disease [CD], 15 for indeterminate colitis [IC], 23 for pouchitis). Only 22.1% of CEs done for CD were normal, as compared to 53.3% for IC and 34.8% for pouchitis. Severe findings in CD consisted of multiple aphthae/ulcers (22.1%), stenosis (8.1%), and stenosis with immediate retention (17.4%). In CD, 61.6% had a change in medication in the 3 months after the CE, with 39.5% initiating a new IBD medication, most commonly budesonide or corticosteroids. In the 3 months following CE, 12.8% of patients with CD underwent surgery. Severe findings on CE in patients with CD, as compared to no/minimal findings, resulted in significant differences in medication changes (73.2% versus 51.1%, P = 0.04), addition of medications (58.5% versus 22.2%, P < 0.01), and surgeries (21.9% versus 4.4%, P = 0.01). CONCLUSIONS: CE results in management changes in the majority of cases of symptomatic IBD, regardless of the subtype of IBD.
BACKGROUND: Capsule endoscopy (CE) is performed to assess inflammatory bowel disease (IBD). We aimed to define the results of CE in subtypes of IBD and to determine whether CE results in management changes. METHODS: A retrospective cohort study was performed of all CEs for IBD at a tertiary care center from 2003-2009. Descriptive statistics were used to compare IBD-specific medications, surgeries, and imaging studies in the 3 months prior and 3 months after CE. RESULTS: Of 907 CEs performed from 2003-2009, 128 were for an indication of symptomatic IBD and 124 capsules left the stomach (86 for Crohn's disease [CD], 15 for indeterminate colitis [IC], 23 for pouchitis). Only 22.1% of CEs done for CD were normal, as compared to 53.3% for IC and 34.8% for pouchitis. Severe findings in CD consisted of multiple aphthae/ulcers (22.1%), stenosis (8.1%), and stenosis with immediate retention (17.4%). In CD, 61.6% had a change in medication in the 3 months after the CE, with 39.5% initiating a new IBD medication, most commonly budesonide or corticosteroids. In the 3 months following CE, 12.8% of patients with CD underwent surgery. Severe findings on CE in patients with CD, as compared to no/minimal findings, resulted in significant differences in medication changes (73.2% versus 51.1%, P = 0.04), addition of medications (58.5% versus 22.2%, P < 0.01), and surgeries (21.9% versus 4.4%, P = 0.01). CONCLUSIONS: CE results in management changes in the majority of cases of symptomatic IBD, regardless of the subtype of IBD.
Authors: I M Gralnek; R Defranchis; E Seidman; J A Leighton; P Legnani; B S Lewis Journal: Aliment Pharmacol Ther Date: 2007-10-23 Impact factor: 8.171
Authors: Barrett G Levesque; Lauren E Cipriano; Steven L Chang; Keane K Lee; Douglas K Owens; Alan M Garber Journal: Clin Gastroenterol Hepatol Date: 2009-11-05 Impact factor: 11.382
Authors: Gian Luigi de' Angelis; Fabiola Fornaroli; Nicola de' Angelis; Barbara Magiteri; Barbara Bizzarri Journal: Am J Gastroenterol Date: 2007-08 Impact factor: 10.864
Authors: C Calabrese; A Fabbri; P Gionchetti; F Rizzello; C Morselli; G Liguori; G Poggioli; M Campieri; G Di Febo Journal: Aliment Pharmacol Ther Date: 2007-06-01 Impact factor: 8.171
Authors: S Mehdizadeh; G Chen; P J Enayati; D W Cheng; N J Han; O A Shaye; A Ippoliti; E A Vasiliauskas; S K Lo; K A Papadakis Journal: Endoscopy Date: 2007-12-05 Impact factor: 10.093
Authors: Pedro Boal Carvalho; Bruno Rosa; Francisca Dias de Castro; Maria João Moreira; José Cotter Journal: World J Gastroenterol Date: 2015-06-21 Impact factor: 5.742
Authors: Ioannis V Mitselos; Dimitrios K Christodoulou; Konstantinos H Katsanos; Epameinondas V Tsianos Journal: World J Gastrointest Endosc Date: 2015-06-10
Authors: Marisol Luján-Sanchis; Laura Sanchis-Artero; Laura Larrey-Ruiz; Laura Peño-Muñoz; Paola Núñez-Martínez; Génesis Castillo-López; Lara González-González; Carlos Boix Clemente; Cecilia Albert Antequera; Ana Durá-Ayet; Javier Sempere-Garcia-Argüelles Journal: World J Gastrointest Endosc Date: 2016-09-16